We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DBE WILL ADD REVIEWERS TO SPEED GENERIC Rx APPROVALS
DBE WILL ADD REVIEWERS TO SPEED GENERIC Rx APPROVALS
November 2, 2004
The Division of Bioequivalence (DBE) in the FDA’s Office of Generic Drugs hopes the addition of more reviewers will help reduce the long wait for generic drug application approvals, according to the division’s chief.